Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIlika Plc Regulatory News (IKA)

Share Price Information for Ilika Plc (IKA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.00
Bid: 27.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 2.00 (7.407%)
Open: 28.00
High: 28.00
Low: 28.00
Prev. Close: 28.00
IKA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Joint Development agreement with Energizer

2 Feb 2012 07:00

RNS Number : 6494W
Ilika plc
02 February 2012
 



Ilika plc

("Ilika" or the "Company")

 

Joint Development agreement with Energizer

 

Ilika plc (AIM: IKA), the advanced cleantech materials discovery company, announces that it has entered into a joint development agreement with Energizer Battery Manufacturing Inc., in the USA, a world leading primary battery manufacturer, for the development of advanced materials.

 

Commenting on the contract, Graeme Purdy, CEO of Ilika, said: "We are delighted to have entered into this new commercial relationship with Energizer and become part of its global innovation network. Energizer has a clear vision for its next generation of products and well defined channels to market."

 

An Energizer spokesperson said: "Ilika's high throughput techniques are well-matched to our material development requirements and we look forward to rapid innovation in this collaboration."

 

For more information contact:

 

Ilika plc

www.ilika.com

Graeme Purdy, Chief Executive

Tel: 023 8011 1400

Steve Boydell, Finance Director

 

 

 

Nomura Code Securities Limited (NOMAD)

Tel: 020 7776 1200

Phil Walker / Christopher Golden

 

 

 

Walbrook PR Ltd

Tel: 020 7933 8780

Paul McManus

Mob: 07980 541 893 or paul.mcmanus@walbrookpr.com

Paul Cornelius

Mob: 07827 879 460 or paul.cornelius@walbrookir.com

 

 

ABOUT ILIKA

 

Ilika is an advanced materials company which accelerates the discovery of new and patentable materials using its unique high throughput technologies (''HTT'') process for identified end uses in the energy, electronics and biomedical sectors. This process enables hundreds of scalable materials to be made in a single, automated operation and subsequently tested for key properties.

 

Traditionally, materials development has been a slow and arduous task, with manual, sequential methods used to make samples of material that are then tested for suitability. On average, it takes between 7 and 10 years to move from an initial discovery through to the first commercial prototype. Experiments carried out by the Company can be executed 10 to 100 times faster than using traditional techniques.

 

The Company focuses on three principal sectors and has a number of active development programmes addressing markets within each sector:

 

Energy - developing innovative new materials for Lithium-ion batteries for vehicles for Toyota; developing high capacity hydrogen storage materials with Shell Hydrogen and Johnson Matthey through joint development programmes; developing cheaper alternatives to Platinum electrodes for use in fuel cells through a grant-funded project with the Carbon Trust; developing new materials for use in fuel cells for the transport sector for a major vehicle manufacturer; and carrying out in-house research on film photovoltaic solar cells.

 

Electronics - developing lead-free piezoelectric materials through a joint development programme with CeramTec; developing phase change memory materials for high capacity memory chips and high-performing electronic materials for a multi-national manufacturer.

 

Biomedical - developing polymers to enable the filtering of somatic stem cells from blood with a major global supplier of filters; it has been selling its Cryoskin and Myskin products for the treatment of burns and wounds in the UK through a specialist distributor and intends to commence clinical trials of its corneal bandage candidate.

 

The Group's commercialisation strategy is to enter into joint development or licensing agreements with large multinational companies which are seeking to commercialise products developed using the intellectual property created through jointly-funded programmes. Current commercialisation partners include large multinational companies such as Toyota, Shell, Johnson Matthey and CeramTec. The Company generates revenues from three sources: licensing and milestone payments from joint development programmes; fee for service from contract research projects; and from sales of Cryoskin and Myskin.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRUASKRUBAURAR
Date   Source Headline
22nd Dec 201411:16 amRNSConversion of Securities
21st Nov 20147:00 amRNSOpening of the pilot line & trading update
28th Oct 20147:00 amRNSDirectorate Changes
26th Sep 20144:07 pmRNSHolding(s) in Company
26th Sep 20143:57 pmRNSHolding(s) in Company
24th Sep 20142:37 pmRNSHolding(s) in Company
24th Sep 20141:00 pmRNSResult of AGM
24th Sep 20147:00 amRNSAGM Statement
23rd Sep 20143:36 pmRNSHolding(s) in Company
23rd Sep 20147:00 amRNSSuccessful Factory Acceptance Test
27th Aug 20147:04 amRNSPosting of Annual Report & Notice of AGM
14th Aug 20147:00 amRNSContract win
23rd Jul 201410:05 amRNSHolding(s) in Company
16th Jul 20147:00 amRNSFinal Results
14th Jul 201412:21 pmRNSConversion of preference shares
11th Jul 20147:00 amRNSProof of Concept Contract Win
10th Jul 20147:00 amRNSCancellation of Conversion of securities
1st Jul 20147:00 amRNSIncrease in Solid-State Battery Size Achieved
20th Jun 20147:00 amRNSNotice of Results
12th May 201411:15 amRNSConversion of Securities
7th May 20147:00 amRNSUK Patents Grants
6th May 201410:28 amRNSConversion of Securities
30th Apr 20145:05 pmRNSConversion of securities and Director Dealings
14th Apr 20142:54 pmRNSConversion of Securities
14th Mar 20145:49 pmRNSHolding(s) in Company
13th Mar 20145:38 pmRNSConversion of Securities
12th Mar 20142:14 pmRNSHolding(s) in Company
12th Mar 20141:14 pmRNSHolding(s) in Company
10th Mar 20144:52 pmRNSHolding(s) in Company
6th Mar 20144:08 pmRNSTotal Voting Rights
26th Feb 20143:50 pmRNSHolding(s) in Company
20th Feb 20147:05 amRNSExercise of warrants
20th Feb 20147:00 amRNSPlacing
14th Feb 20143:45 pmRNSConversion of Securities
11th Feb 20147:00 amRNSGrant funding for Superalloys
10th Feb 20147:00 amRNSCommercial Update & Conversion of Securities
30th Jan 20144:28 pmRNSHolding(s) in Company
28th Jan 20145:04 pmRNSHolding(s) in Company
28th Jan 201411:30 amRNSHolding(s) in Company
28th Jan 20147:00 amRNSValidation of Worlds 1st Solid State Battery
24th Jan 201411:05 amRNSHolding(s) in Company
23rd Jan 20144:50 pmRNSHolding(s) in Company
20th Jan 20147:00 amRNSHolding(s) in Company
15th Jan 20147:00 amRNSInterim Results
13th Jan 20144:28 pmRNSHolding(s) in Company
10th Jan 20144:09 pmRNSHolding(s) in Company
9th Jan 20147:00 amRNSWorld first for Ilika solid state battery
13th Dec 20137:00 amRNSFuel Cell Catalyst Patent Granted in Europe
2nd Dec 20134:16 pmRNSHolding(s) in Company
12th Nov 20137:00 amRNSHalf Year Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.